Laboratory monitoring for HIV disease in resource-limited settings has now become one of the key challenges for antiretroviral treatment (ART) access and success, as emphasized by the 2010 revised WHO ...

SANTA CLARA, Calif--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) announced today an extension to its digital lab capabilities with Agilent CrossLab Asset Monitoring, an advanced service for ...

The manner in which scientists gather and use data is being changed through Internet of Things (IoT) technology. The ability to monitor the status of their instruments and equipment, as well as the ...

Please provide your email address to receive an email when new articles are posted on . Few adverse events were reported in OPAT containing cefazolin and ceftriaxone. Only 2.7 clinically significant ...

The rapid expansion of antiretroviral treatment (ART) programs in low- and middle-income countries in recent years has produced dramatic declines in mortality. Laboratory monitoring for HIV disease in ...

SANTA CLARA, Calif--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today an extension to its digital lab capabilities with Agilent CrossLab Asset Monitoring, an advanced service for ...